•Brent rose 3.7% to $112.80 a barrel on Thursday after touching a 5-month high.
•WTI closed on Wednesday at $97.15 a barrel, down 67 cents, or 0.7%.
•The Energy Information Administration forecast an average Brent spot price of $105 in the fourth quarter of 2026, up $14 from the previous month's estimate.
•Deutsche Boerse values the Allfunds acquisition at about 5.3 billion euros.
•The total announced consideration is 8.80 euros per share, including cash, shares and the permitted dividend.
•Support for the scheme of arrangement and the associated special resolution exceeded 99.9% of the value of votes cast at the two relevant shareholder meetings.
•The average U.S. on-highway diesel price reached $6.276 per gallon on October 19, 2026, compared with $6.179 on October 12 and $3.620 on October 20, 2025.
•U.S. operable atmospheric distillation capacity fell to 18.2 million barrels per calendar day on January 1, 2026, down more than 250,000 barrels per day, or about 1%, from January 1, 2025.
•U.S. refinery capacity utilization reached 98%, according to the latest data cited by Reuters in its September report.
•U.S. operable refining capacity stood at 18.2 million barrels per day at the start of 2026, down by more than 250,000 barrels per day, or about 1%, from the start of 2025.
•The average U.S. regular gasoline price fell to $4.284 per gallon on October 19, 2026, from $4.331 on October 12.
•U.S. gasoline inventories were 3.8% below the 5-year average for the week ended October 9, 2026.
•Research and development expenses totaled $10.5 million in the second quarter of 2026, compared with $13.1 million in the corresponding period of 2025.
•The company estimated in its August update that its cash resources were sufficient to fund anticipated operations into late 2027.
•Aardvark confirmed that the U.S. Food and Drug Administration had lifted the clinical hold on its experimental treatment for Prader-Willi syndrome.
•The placebo-adjusted reduction in systolic blood pressure was 9.6 mmHg in patients with chronic kidney disease, versus 12.2 mmHg in those without the condition.
•The analysis included 800 participants, including 192 with chronic kidney disease.
•A post hoc analysis showed a reduction in albuminuria of about 52% among participants with elevated levels at baseline.
•The preliminary registration prospectus covers various securities with an aggregate ceiling of up to $50 million.
•The August offering raised gross proceeds of about $3.2 million from the sale of 943,676 shares following the full exercise of the overallotment option, before discounts, commissions and expenses.
•Cash stood at about $0.21 million, liabilities at $12.8 million and the accumulated deficit at $28.2 million at the end of June 2026, before the August financing.
•Nasdaq gave Atlantic American until October 12, 2026, to regain compliance after it submitted a plan.
•The credit agreement extends the deadline for delivering audited annual financial statements and compliance certificates to Truist Bank to October 23, 2026.
•The deadline for delivering interim financial statements required by the lender extends to November 30, 2026.
